What is Edumedics?
Edumedics provides a unique healthcare delivery model targeting populations such as self-insured employers and Medicare Advantage groups. The company deploys Nurse Practitioners to offer direct, face-to-face care for individuals managing chronic conditions like diabetes and hypertension, or those at risk. Utilizing its proprietary Healthward technology at the point of care, Edumedics has demonstrated a clear impact on improving health outcomes and reducing costs, with reported yearly cost reductions of up to 15% for clients and significant clinical improvements. Notably, one client saw diabetes improvement exceeding 52% among high-risk members. Founded in 2010 by Alice Shade and Dr. Richard Goldstein, the company emerged from a recognized need for better chronic care management, initially developing its intellectual property for the University of Louisville's employee population before spinning out to serve broader markets.
How much funding has Edumedics raised?
Edumedics has raised a total of $7.2M across 4 funding rounds:
Private Equity
$1.1M
Debt
$780K
Private Equity
$1.2M
Series A
$4.2M
Private Equity (2013): $1.1M, investors not publicly disclosed
Debt (2014): $780K, investors not publicly disclosed
Private Equity (2015): $1.2M, investors not publicly disclosed
Series A (2015): $4.2M featuring OCA Ventures and Lunsford Capital, LLC
Key Investors in Edumedics
OCA Ventures
OCA Ventures is a venture capital firm dedicated to supporting entrepreneurs and fostering the growth of successful companies. They provide essential resources and strategic guidance to startups, with a focus on driving innovation and market penetration.
Lunsford Capital, LLC
Lunsford Capital is a private investment firm based in Louisville, Kentucky, with a diversified portfolio across healthcare, technology, and real estate. They invest in innovative ventures and provide leadership to help companies achieve significant growth and success.
What's next for Edumedics?
The recent major strategic investment positions Edumedics for accelerated expansion and further development of its technology-driven healthcare solutions. With a proven track record of reducing costs and improving clinical outcomes for employers and health plans, this capital infusion is expected to fuel the company's efforts to reach more individuals with chronic conditions. The focus will likely remain on enhancing the Healthward platform and broadening its service reach within the enterprise and Medicare Advantage segments, solidifying its role as a key player in innovative health delivery.
See full Edumedics company page
